The percentage of patients with in the overall and high risk population with gastroesophogeal reflux disease (GERD) with alarm symptoms who have had an upper gastrointestinal study. (2 separate Denominators)
Measure Specs
General Information
Numerator
Patients who have had at least least 1 esophageal procedure, upper GI study (Upper GI radiologic exam with high density barium, with or without delayed films, eshophageal or gastric motility study, gastric emptying study,gastric analysis test, upper GI endoscopy, or upper GI series), or gastrectomy or evidence of at least 1 gastric or esophageal cancer diagnosis in the past 12 months. *Note-cancer diagnosis implies diagnostic testing was done, and therefore completes numerator
Denominator
Denominator 1:Patients with a diagnosis of chronic GERD with alarm symptoms (e.g., dysphagia, iron deficiency anemia, weight loss)in the past 12 months.
Denominator 2:High risk patients (i.e., obese, male, or age > 50) with a diagnosis of GERD with alarm symptoms (i.e., dysphagia or weight loss) in the past 12 months
Exclusions
Specific Exclusions:
1. Patients with esophageal varices.
2. Patients with gastric restrictive procedures.
3. Patients with weight loss surgery.
4. 1. Patients with a metastatic malignancy,
General exclusions:
1. Evidence of metastatic disease or active treatment of malignancy
(chemotherapy or radiation therapy) in the last 6 months
2. Patients who have been in a skilled nursing facility in the last 3 months
3. Patients who are terminally ill or in Hospice
Measure Record
Point of Contact
This information, including any attachments hereto, is the sole, exclusive, proprietary and confidential property of ActiveHealth Management, Inc., and is for the exclusive use of The National Quality Forum. Any use, copying, disclosure, dissemination or distribution by anyone other than the National Quality Forum is strictly prohibited.
Public Comments